🔎 Trials Near Me

Akèy › Kansè tiwoyid › Tennessee

Etid klinik pou Kansè tiwoyid nan Tennessee

8 etid pou Kansè tiwoyid ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

DESTINY-PANTUMOUR04

  • Research Site, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Sarah Canon Research Institute (SCRI) Oncology Partners, Nashville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2
Laj 2 a 25 · Tout sèks · Mizajou Jul 24, 2026 · NCT06458036

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Nashville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist (BHMCC), Memphis
  • Vanderbilt-Ingram Cancer Center, Nashville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2
Laj 2 a 99 · Tout sèks · Mizajou Nov 14, 2025 · NCT05783323

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer

  • Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 28, 2025 · NCT05999630

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.